Bottom line
What is UBVAX's expense ratio?
UBVAX's expense ratio is 1.24%, or about $124 a year on every $10,000 invested. That is more expensive than 81% of large value funds we track (median 0.81%). This share class also charges a front-end sales load of up to 5.25%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Oct 20, 2026
UBVAX fee table
| Net expense ratio | 1.24% |
|---|---|
| Gross expense ratio | 1.35% |
| Management fee | 0.75% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.35% |
| Fee waiver / reimbursement | -0.11% |
| Max front-end sales load | 5.25% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Oct 20, 2026
What UBVAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| UBVAX | $645 | $920 | $1,216 | $2,055 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.24% expense ratio costs roughly $67,300 in lost growth, versus about $45,600 for the median large value fund (0.81%).